NFKB1 and neoplasm: This modeling provides useful insights to confirm our findings that in the presence of macrophage-associated cytokines and chemokines, activation of JAK-STAT and PI3K-AKT pathways can restore survival and proliferation of tumor cells to compensate the decreased activity of NFKB by Etanercept.